54 The epidermal growth factor receptor tyrosine kinase inhibitor, eriotinib (Tarceva TM, OSI-774), is an active agent in bronchioloalveolar carcinoma (BAC) and its variants: interim results of a phase II trial
J. Patel, V. Miller, M. Kris, N. Shah, L. Tyson, B. Pizzo, M. Zakowski, M. Cespon, R. Heelan, D. JohnsonVolume:
1
Year:
2003
Language:
english
DOI:
10.1016/s1359-6349(03)90089-9
File:
PDF, 168 KB
english, 2003